-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: Enliven Therapeutics Appoints Kristine Ball to Board of Directors Ahead of Planned Phase 3 Trial Initiation this Year

Dow Jones·10/14/2026 20:30:00

Please log in to view news